drugset / Trial / NCT05394402

A Trial of SHR0410 Injection in Postsurgical Pain Management

NCT05394402

Phase 2 Terminated 31 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy, safety of SHR0410 Injection and to explore the reasonable of SHR0410 Injection for Pain Management after Orthopaedic Surgery.

Timeline

Start
2022-08-09
Primary completion
2023-05-31
Completion
2023-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR0410 Unknown

Indications

No indication recorded.